Key result
Age ≥75 in ACS is linked to ~112% higher in-hospital mortality risk versus age ≤74.
Why the study?
This study was conducted to describe differences in treatment and clinical outcomes between patients aged ≥75 years and those aged ≤74 years presenting with ACS and undergoing invasive management.
Does age ≥75 years compared to ≤74 years affect treatment patterns and mortality in patients with acute coronary syndrome undergoing invasive management?
Cohort (n=11,763)
Yes
Does age ≥75 years compared to ≤74 years affect treatment patterns and mortality in patients with acute coronary syndrome undergoing invasive management?
Older patients (≥75 years) with ACS undergoing invasive management have higher in-hospital mortality and receive less secondary prevention, but age itself is not an independent predictor of long-term mortality.
Answers are grounded in this paper and cite their sources.
Supports heightened in-hospital vigilance for ACS patients ≥75 years; leaves open age as independent 1-year mortality predictor.
OBJECTIVE: This study describes the differences in treatment and clinical outcomes in patients aged ≥75 years compared with those aged ≤74 years presenting with acute coronary syndrome (ACS) and undergoing invasive management. METHODS: A large-scale cohort study of patients with ST-elevation/non-ST-elevation myocardial infarction (MI)/unstable angina underwent coronary angiography (January 2015-December 2019). Patients were classified as older (≥75 years) and younger (≤74 years). Regression analysis was used to yield adjusted risks of mortality for older versus younger patients (adjusted for history of heart failure, hypercholesterolaemia, peripheral vascular disease, chronic obstructive pulmonary disease, ischaemic heart disease, presence of ST-elevation MI on presenting ECG, female sex and cardiogenic shock at presentation). RESULTS: In total, 11 763 patients were diagnosed with ACS, of which 39% were aged ≥75 years. Percutaneous coronary intervention was performed in fewer older patients than younger patients (81.2% vs 86.2%, p<0.001). At discharge, older patients were prescribed less secondary-prevention medications than younger patients. Median follow-up was 4.57 years. Older patients had a greater risk of in-hospital mortality than younger patients (adjusted OR (aOR) 2.12, 95% CI 1.62 to 2.78, p<0.001). Older patients diagnosed with ST-elevation MI had greater adjusted odds of dying in-hospital (aOR 2.47, 95% CI 1.79 to 3.41, p<0.001). Older age was not an independent prognostic factor of mortality at 1 year (adjusted HR (aHR) 0.95, 95% CI 0.82 to 1.09, p=0.460) and at longer term (aHR 0.98, 95% CI 0.87 to 1.10, p=0.684). CONCLUSIONS: Older patients are discharged with less secondary prevention. Patients aged ≥75 years are more likely to die in-hospital than younger patients.
No takes yet. Share an insight, caveat, or question.
Lawless et al. (2023) conducted a cohort in Acute coronary syndrome (ACS) (n=11,763). Age ≥75 years vs. Age ≤74 years was evaluated on In-hospital mortality (aOR 2.12, 95% CI 1.62-2.78, p=<0.001). Patients aged ≥75 years presenting with ACS had a greater risk of in-hospital mortality compared to those aged ≤74 years.
Synapse has enriched 10 related papers. Consider them for comparative context: